In our original article, we identified a key issue in the visualization of metabolite concentrations. Specifically, values below 100 ng/ml were wrongly formatted, which impacted figures.
The recent clinical trial published in JAMA Oncology revealed that a combination treatment of a PARP inhibitor and chemotherapy did not improve survival in glioblastoma patients compared to placebo.
"As the summer comes to an end, I can't tell you what a relief it is to have finally completed my chemotherapy treatment. Doing what I can to stay cancer free is now my focus" - Catherine, Princess of Wales.